Creative Planning’s Ascendis Pharma A/S ASND Stock Holding History

Creative Planning’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Buy	8,356 +403	+5%	+$94.1K	﹤0.01%	2006
2026 Q1	$1.82M	Buy	7,953 +1,162	+17%	+$260K	﹤0.01%	1972
2025 Q4	$1.45M	Buy	6,791 +170	+3%	+$35.1K	﹤0.01%	1984
2025 Q3	$1.32M	Buy	6,621 +1,238	+23%	+$231K	﹤0.01%	1871
2025 Q2	$929K	Buy	5,383 +1,746	+48%	+$284K	﹤0.01%	1925
2025 Q1	$567K	Buy	3,637 +166	+5%	+$23.7K	﹤0.01%	2174
2024 Q4	$478K	Buy	+3,471	New	+$456K	﹤0.01%	2263
2021 Q3	–	Sell	-1,900	Closed	-$250K	–	2122
2021 Q2	$250K	Sell	1,900 -1,679	-47%	-$224K	﹤0.01%	1664
2021 Q1	$461K	Sell	3,579 -1,955	-35%	-$297K	﹤0.01%	1490
2020 Q4	$923K	Buy	+5,534	New	+$915K	﹤0.01%	992
2017 Q3	–	Sell	-350	Closed	-$10K	–	2005
2017 Q2	$10K	Hold	350	–	–	﹤0.01%	3608
2017 Q1	$10K	Buy	+350	New	+$8.85K	﹤0.01%	3576

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Creative Planning's ASND Position: Q2 2026 in Review

Creative Planning increased its Ascendis Pharma A/S (ASND) stake by 5.1% in Q2 2026, buying an estimated $94.1K and bringing the position to 8,356 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Creative Planning first reported a position in ASND in Q1 2017 and has held it in 12 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Creative Planning held 8,356 shares of Ascendis Pharma A/S worth $2.23M as of Q2 2026.
Creative Planning bought 403 Ascendis Pharma A/S shares in Q2 2026, an estimated $94.1K.
Ascendis Pharma A/S made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2006 holding.
Creative Planning first reported a position in Ascendis Pharma A/S in Q1 2017 and has held it in 12 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.